These findings suggest that FOXO1 can protect against excessive hepatic lipid production during hyperglycemia and may indicate that insulin treatment, which inhibits FOXO1, may indirectly worsen lipid abnormalities in diabetics [70]. This evidence concerns the gene FOXO1 and Hyperglycemia.